Trial in Progress Update on Engotcx8/Gog-3024/Innovatv 205: Addition of A New Cohort Using First-Line Tisotumab Vedotin Plus Pembrolizumab Plus Carboplatin - Bevacizumab in Recurrentimetastatic Cervical Cancer

Vergote, IgnaceMirza, MansoorSehouli, JalidLorusso, DomenicoKose, FatihCibula, DavidWestermann, AnnekeCollins, DearbhaileBanerjee, SusanaOaknin, AnaSoumaoro, IbrahimaJain, ShwetaMonk, Bradley J.2023-09-152023-09-1520221048-891Xhttps://ijgc.bmj.com/content/ijgc/32/Suppl_2/A64.1.full.pdfhttp://hdl.handle.net/11727/10676enginfo:eu-repo/semantics/openAccessTrial in Progress Update on Engotcx8/Gog-3024/Innovatv 205: Addition of A New Cohort Using First-Line Tisotumab Vedotin Plus Pembrolizumab Plus Carboplatin - Bevacizumab in Recurrentimetastatic Cervical CancerconferenceObject32Supplement 2A64A640008990777001391525-1438